Skip to main content
. Author manuscript; available in PMC: 2020 Jul 1.
Published in final edited form as: Lancet Oncol. 2019 May 28;20(7):1011–1022. doi: 10.1016/S1470-2045(19)30277-3

Table 1.

Patient demograhic data on both strata 1 and 3

Stratum 1 (N=25) Stratum 3 (N=25)
AGE (Years) at Diagnosis
 Median/Range/IQR 4.4/0.3–19.1/2.01–8.45 3.1/0.6–12.2/6.63–12.71
AGE (Years) at Study Entry
 Median/Range/IQR 9.2/3.9–20.8/6.88–12.44 10.2/3.5–16.6/7.49–12.90
SEX (Number (%)
 Males 12 (48) 15 (60)
 Females 13 (52) 10 (40)
ETHNICITY (Number (%)
 Hispanic or Latino 3 (12)
 Non-Hispanic 22 (88) 24 (96)
Unknown 1 (4)
PRIOR # of THERAPIES
Median/Range/IQR 4/2–9/3–5 3/1–9/2–4
RACE (Number (%)
 Asian 1 (4)
 Black 1 (4)
 Unknown 0 (0) 3 (12)
 White, Non-Hispanic 23 (92) 22 (88)
DIAGNOSIS (Number (%)
Astrocytoma, NOS 2 (8)
 Glioma, NOS 19 (76)
 Pilocytic Astrocytoma 25 (100) 4 (16)
LOCATION (Number (%)
Brain Stem 6 (24) 5 (20)
Brain, NOS - 1 (4)
Cerebellum, NOS 2 (8) -
Cisterna Interpeduncularis 1 (4) -
Corpus Callosum, NOS - 2 (8.0)
Cerebral Hemisphere 2 (8) 2 (8)
 Hypothalamus, NOS 9 (36) 2 (8.0)
 Lateral Ventricle, NOS 1 (4) -
 Optic Tract 1 (4) 13 (52)
Supratentorial Brain, NOS 1 (4) -
Thalamus, NOS 2 (8) -